top of page

When Every Minute Counts: Allergic Reaction Deaths in U.S. Children



ree

The Hidden Risk in Childhood Allergies


Severe allergic reactions, known as anaphylaxis, can become fatal within minutes. In the United States, deaths among young children are rare, but when they occur, they highlight preventable gaps in recognition, treatment, and equitable access to care.


How Common Are Fatal Allergic Reactions?


National data from 1999–2010 recorded 2,458 anaphylaxis-related deaths across all ages. Most involved medications in older adults, but fatal food reactions clustered in children and teens. Pediatric fatalities are so uncommon that many reports come from single states or case registries.


Overall, the risk of death remains very low, well under 1 death per million people per year, but the impact is devastating for families and communities.


What Do Pediatric Fatalities Have in Common?


Leading Triggers

  • Foods dominate in children.

  • Peanuts, tree nuts, and cow’s milk are most often reported.


Risk Factors

  • Asthma is present in many fatalities, especially if poorly controlled.

  • Black children have higher rates of severe outcomes and deaths, reflecting broader disparities in diagnosis and access to care.


Delayed Treatment

  • In most cases, epinephrine was not used promptly.

  • Families or caregivers sometimes relied on antihistamines or waited too long before calling for help.


Where and When Do Tragedies Happen?

  • Most deaths occur outside the hospital: at home, in restaurants, or in schools.

  • Hesitation to use epinephrine or lack of an available device are recurring problems.


Progress in Policy and Care

  • School Stock Epinephrine: Nearly every state now allows or requires schools to keep epinephrine on hand. Implementation varies in training and coverage.

  • Needle-Free Option: The FDA approved neffy, an intranasal epinephrine spray, for children four years and older, which may reduce hesitation and speed up treatment.

  • Clearer Labels: The FASTER Act added sesame to the list of major allergens in 2023, helping families avoid accidental exposures.

  • Infant Prevention: Studies show that early peanut introduction lowers the risk of peanut allergy by up to 80%, offering long-term protection.


Preventing Future Deaths


For Families

  • Always carry epinephrine, with two doses available.

  • Act quickly: epinephrine first, then call 911.

  • Share an emergency plan with schools and caregivers.

  • Control asthma carefully in children with allergies.

  • Discuss early peanut introduction with pediatricians for infants.


For Schools and Communities

  • Stock epinephrine devices and train staff.

  • Run drills so responders know how to act without hesitation.

  • Make sure action plans are in place for both diagnosed and undiagnosed children.


Why This Matters

Every pediatric death from an allergic reaction is rare, but nearly always preventable. Rapid use of epinephrine, improved asthma care, and equitable access to allergy diagnosis and devices can save lives. With better policies and consistent education, these tragedies can become even rarer.


References

  1. Jerschow E, et al. Fatal anaphylaxis in the United States, 1999–2010. J Allergy Clin Immunol. 2014;133(4):1075-1083.

  2. Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001;107(1):191–193.

  3. Bock SA, Muñoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001–2006. J Allergy Clin Immunol. 2007;119(4):1016–1018.

  4. Shaker M, Wallace DV, Golden DBK, et al. Anaphylaxis: A 2023 practice parameter update. Ann Allergy Asthma Immunol. 2023;131(3):243–259.

  5. U.S. Food and Drug Administration. FDA Approves First Epinephrine Nasal Spray. 2024.

  6. Togias A, et al. Addendum guidelines for the prevention of peanut allergy. J Allergy Clin Immunol. 2017;139(1):29–44.

  7. Food Allergy Safety, Treatment, Education, and Research (FASTER) Act of 2021, Pub. L. No. 117-11.


Assessed and Endorsed by the MedReport Medical Review Board

 
 

©2025 by The MedReport Foundation, a Washington state non-profit organization operating under the UBI 605-019-306

 

​​The information provided by the MedReport Foundation is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. The MedReport Foundation's resources are solely for informational, educational, and entertainment purposes. Always seek professional care from a licensed provider for any emergency or medical condition. 
 

bottom of page